CN101377502A - 肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 - Google Patents
肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN101377502A CN101377502A CNA2007101211688A CN200710121168A CN101377502A CN 101377502 A CN101377502 A CN 101377502A CN A2007101211688 A CNA2007101211688 A CN A2007101211688A CN 200710121168 A CN200710121168 A CN 200710121168A CN 101377502 A CN101377502 A CN 101377502A
- Authority
- CN
- China
- Prior art keywords
- associated antigen
- tumor
- enzyme
- kit
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 56
- 239000000427 antigen Substances 0.000 title claims abstract description 54
- 102000036639 antigens Human genes 0.000 title claims abstract description 54
- 108091007433 antigens Proteins 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 title description 7
- 238000004458 analytical method Methods 0.000 title description 4
- 102000004190 Enzymes Human genes 0.000 claims abstract description 35
- 108090000790 Enzymes Proteins 0.000 claims abstract description 35
- 238000000576 coating method Methods 0.000 claims abstract description 23
- 239000007790 solid phase Substances 0.000 claims abstract description 23
- 239000011248 coating agent Substances 0.000 claims abstract description 20
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 238000003018 immunoassay Methods 0.000 claims abstract description 16
- 239000000243 solution Substances 0.000 claims description 25
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 239000007853 buffer solution Substances 0.000 claims description 14
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 11
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 10
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 8
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 claims description 6
- 239000011324 bead Substances 0.000 claims description 5
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 5
- 239000006249 magnetic particle Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- QWXOJIDBSHLIFI-UHFFFAOYSA-N [3-(1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC2CC(Cl)(C4)C3)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 QWXOJIDBSHLIFI-UHFFFAOYSA-N 0.000 claims description 4
- UKWLRLAKGMZXJC-QIECWBMSSA-L disodium;[4-chloro-3-[(3r,5s)-1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl]phenyl] phosphate Chemical compound [Na+].[Na+].O1OC2([C@@H]3CC4C[C@H]2CC(Cl)(C4)C3)C1(OC)C1=CC(OP([O-])([O-])=O)=CC=C1Cl UKWLRLAKGMZXJC-QIECWBMSSA-L 0.000 claims description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 4
- 238000002372 labelling Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 150000000077 1,2-dioxanes Chemical class 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims 3
- 238000003149 assay kit Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 8
- 239000013598 vector Substances 0.000 abstract 2
- 238000004806 packaging method and process Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 7
- 239000012154 double-distilled water Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000005718 Stomach Neoplasms Diseases 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 206010017758 gastric cancer Diseases 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 201000011549 stomach cancer Diseases 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003593 chromogenic compound Substances 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- -1 (adamantane) -1, 2-dioxane Chemical group 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- YJTQIDFYMMHODK-UHFFFAOYSA-N 3-phenyldioxane Chemical compound C1CCOOC1C1=CC=CC=C1 YJTQIDFYMMHODK-UHFFFAOYSA-N 0.000 description 1
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XYIPYISRNJUPBA-UHFFFAOYSA-N [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC(C3)CC2C4)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 XYIPYISRNJUPBA-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101211688A CN101377502A (zh) | 2007-08-31 | 2007-08-31 | 肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101211688A CN101377502A (zh) | 2007-08-31 | 2007-08-31 | 肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101377502A true CN101377502A (zh) | 2009-03-04 |
Family
ID=40421146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101211688A Pending CN101377502A (zh) | 2007-08-31 | 2007-08-31 | 肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101377502A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102890083A (zh) * | 2012-09-28 | 2013-01-23 | 辽宁科骏生物有限公司 | 化学发光底物溶液和含其的试剂盒及应用其的检测方法 |
CN111198271A (zh) * | 2018-11-16 | 2020-05-26 | 山东泽济生物科技有限公司 | 一种用于甘油醛-3-磷酸脱氢酶检测的化学发光酶联免疫试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0394510A1 (en) * | 1989-04-24 | 1990-10-31 | Mochida Pharmaceutical Co., Ltd. | Method for assaying a tumor-associated antigen in a minute amount of nipple discharge and device for such an assay |
JPH02280061A (ja) * | 1989-04-20 | 1990-11-16 | Mochida Pharmaceut Co Ltd | 微量の乳頭分泌液中の腫瘍関連抗原の測定方法および測定用器材 |
CN1811437A (zh) * | 2006-02-16 | 2006-08-02 | 中国农业大学 | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 |
WO2007081768A2 (en) * | 2006-01-04 | 2007-07-19 | Fujirebio America, Inc. | Use of he4 and other biochemical markers for assessment of ovarian cancers |
CN101021535A (zh) * | 2007-03-12 | 2007-08-22 | 北京望尔康泰生物技术有限公司 | 检测庆大霉素药物的酶联免疫试剂盒及方法 |
-
2007
- 2007-08-31 CN CNA2007101211688A patent/CN101377502A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02280061A (ja) * | 1989-04-20 | 1990-11-16 | Mochida Pharmaceut Co Ltd | 微量の乳頭分泌液中の腫瘍関連抗原の測定方法および測定用器材 |
EP0394510A1 (en) * | 1989-04-24 | 1990-10-31 | Mochida Pharmaceutical Co., Ltd. | Method for assaying a tumor-associated antigen in a minute amount of nipple discharge and device for such an assay |
WO2007081768A2 (en) * | 2006-01-04 | 2007-07-19 | Fujirebio America, Inc. | Use of he4 and other biochemical markers for assessment of ovarian cancers |
CN1811437A (zh) * | 2006-02-16 | 2006-08-02 | 中国农业大学 | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 |
CN101021535A (zh) * | 2007-03-12 | 2007-08-22 | 北京望尔康泰生物技术有限公司 | 检测庆大霉素药物的酶联免疫试剂盒及方法 |
Non-Patent Citations (1)
Title |
---|
魏慧斌 等: "水体及人体液中的***的高灵敏度化学发光酶免疫分析", 《分析化学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102890083A (zh) * | 2012-09-28 | 2013-01-23 | 辽宁科骏生物有限公司 | 化学发光底物溶液和含其的试剂盒及应用其的检测方法 |
CN111198271A (zh) * | 2018-11-16 | 2020-05-26 | 山东泽济生物科技有限公司 | 一种用于甘油醛-3-磷酸脱氢酶检测的化学发光酶联免疫试剂盒 |
CN111198271B (zh) * | 2018-11-16 | 2023-04-28 | 山东泽济生物科技有限公司 | 一种用于甘油醛-3-磷酸脱氢酶检测的化学发光酶联免疫试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101377501A (zh) | 细胞角蛋白19片段化学发光免疫分析测定试剂盒及其制备方法 | |
CN106501515A (zh) | Ca215检测试剂盒及其制备方法和使用方法 | |
CN101377500A (zh) | 游离***特异性抗原化学发光免疫分析测定试剂盒及其制备方法 | |
PT92828B (pt) | Metodo de ensaio relativo a receptores de ligandos limite | |
CN108333357A (zh) | 一种磁珠时间分辨荧光免疫定量检测ck-mb试剂盒 | |
CN109975559B (zh) | 一种时间分辨荧光定量检测25羟基维生素d的试剂盒及方法 | |
US5958339A (en) | Format for immunoassay in thin film | |
CN203405464U (zh) | 定量检测胃蛋白酶原ii的时间分辨免疫层析试纸条及使用其的试纸卡 | |
CN101368969A (zh) | Ⅳ型胶原蛋白化学发光免疫分析定量测定试剂盒及其制备方法 | |
JP2000508075A (ja) | 発光特異的結合アッセイ | |
CN102721813A (zh) | ***特异抗原均相发光免疫分析检测试剂盒及其检测方法 | |
CN108398563A (zh) | 一种双标记磁珠时间分辨荧光免疫定量检测cTnI和H-FABP试剂盒 | |
CN106771239A (zh) | 血清淀粉样蛋白a/降钙素原/c‑反应蛋白三合一测定试剂盒及制法 | |
CN102226808A (zh) | 胰蛋白酶原-2化学发光免疫检测试剂盒及其制备方法 | |
CN109239326A (zh) | 基于磁颗粒纳米酶的微流控免疫芯片分析方法及应用 | |
CN108181287A (zh) | 一种磁珠时间分辨荧光免疫定量检测h-fabp试剂盒 | |
CN116539886A (zh) | 检测超敏心肌肌钙蛋白i含量的检测卡、试剂盒及检测方法 | |
CN101545911A (zh) | 细胞角蛋白18化学发光免疫分析定量测定试剂盒及其制备方法 | |
CN220690951U (zh) | 一种检测心肌肌钙蛋白i的试剂盒 | |
CN101377498A (zh) | ***特异性抗原化学发光免疫分析测定试剂盒及其制备方法 | |
CN109633163B (zh) | 降钙素原/c反应蛋白二合一检测试剂盒 | |
CN101377502A (zh) | 肿瘤相关抗原72-4化学发光免疫分析测定试剂盒及其制备方法 | |
CN101377499A (zh) | 神经特异性烯醇化酶化学发光免疫分析测定试剂盒及其制备方法 | |
JPH0772152A (ja) | 特異的バインディングアッセイ方法及び分析要素 | |
CN116413444A (zh) | 一种检测总三碘甲状腺原氨酸含量的试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING KEMEI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: KEMEI DONGYA BIOLOGICAL TECHNOLOGY CO., LTD., BEIJING Effective date: 20111027 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20111027 Address after: 100094 Beijing city Haidian District Yongfeng base Feng Xian Road No. 7 North Park Applicant after: Beijing Kemei Biological Technology Co., Ltd. Address before: 100094 Beijing city Haidian District Yongfeng base Feng Xian Road No. 7 North Park Applicant before: Kemei Dongya Biological Technology Co., Ltd., Beijing |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090304 |